DD vs MCRB · P/E 127, rev $3.50B vs rev $1.1M
Dupont De Nemours Inc (DD) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the DD and MCRB stock pages for the full models.
Not investment advice.